Your browser doesn't support javascript.
loading
Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study.
Lindholm, C; Olofsson, E; Creignou, M; Nilsson, L; Garelius, H Gravdahl; Cammenga, J; Ljungman, P; Ejerblad, E; Tobiasson, M.
Afiliación
  • Lindholm C; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. carolin.lindholm@ki.se.
  • Olofsson E; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Creignou M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Nilsson L; Department of Hematology, Oncology and radiation physics, Skåne University Hospital, Lund, Sweden.
  • Garelius HG; Section of Hematology and Coagulation, Specialist Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Cammenga J; Department of Hematology, BKV and CKOC, Linköping University Hospital and Linköping University, Linköping, Sweden.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge and Division of Hematology, Dept of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Ejerblad E; Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Section of Hematology, Uppsala University Hospital, Uppsala, Sweden.
  • Tobiasson M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Bone Marrow Transplant ; 57(4): 598-606, 2022 04.
Article en En | MEDLINE | ID: mdl-35105966

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Suecia